{
  "atsdr-cdc-pfas-fast-facts": {
    "bytes": 62813,
    "captured_at": "2026-07-03",
    "claim": "pfas: nearly all US people have measurable PFAS in blood",
    "confirming_quote": "Nearly all people in the U.S. have PFAS in their blood",
    "content_type": "html",
    "fetched_from": "http://web.archive.org/web/20260702092150/https://www.atsdr.cdc.gov/pfas/data-research/facts-stats/index.html",
    "file": "receipts/sources/atsdr-cdc-pfas-fast-facts.htm",
    "inert": true,
    "raw_sha256": "38d027f2c48d161ea23117ce1203f04beca505205307d7d3eafb05e0565f40b7",
    "sha256": "90434c00c3f6f93c800fdb518eb2d39cddba3ce64afad0f2d199755c2ff200d7",
    "slug": "atsdr-cdc-pfas-fast-facts",
    "title": "PFAS in the U.S. Population — Fast Facts (ATSDR/CDC)",
    "url": "https://www.atsdr.cdc.gov/pfas/data-research/facts-stats/index.html"
  },
  "cacciottolo-2017-whims-apoe": {
    "bytes": 425385,
    "captured_at": "2026-06-09",
    "claim": "research/pm-alzheimers §3 ref [1] (WHIMS cohort)",
    "confirming_quote": "Particulate air pollutants, APOE alleles and their contributions to cognitive impairment in older women and to amyloidogenesis in experimental models",
    "fetched_from": "https://doi.org/10.1038/tp.2016.280",
    "file": "receipts/sources/cacciottolo-2017-whims-apoe.htm",
    "inert": true,
    "raw_sha256": "e9c8a847bf1af2c575a7c23c0bb53840a88715ae4e420eda7521d4ea8cef4013",
    "sha256": "ac282843f652ebb752809daf22a95e7c26a305291998a35dff54052167f6f786",
    "slug": "cacciottolo-2017-whims-apoe",
    "title": "Cacciottolo et al. 2017, Translational Psychiatry — PM, APOE & cognitive impairment in older women",
    "url": "https://doi.org/10.1038/tp.2016.280"
  },
  "cdc-national-biomonitoring-program": {
    "bytes": 50311,
    "captured_at": "2026-07-03",
    "claim": "pfas: CDC NBP measured hundreds of chemicals in blood/urine",
    "confirming_quote": "exposure to environmental chemicals using biomonitoring",
    "content_type": "html",
    "fetched_from": "http://web.archive.org/web/20260616154421/https://www.cdc.gov/biomonitoring/resources/national-exposure-report.html",
    "file": "receipts/sources/cdc-national-biomonitoring-program.htm",
    "inert": true,
    "raw_sha256": "2ad025c8de7e7c193168677e6f643df74e064373506b5c121613ef7dbe38de4d",
    "sha256": "cad3cde08230565e52c82d81e179fee922fea917fbdc084c86e8bacf7fd81e14",
    "slug": "cdc-national-biomonitoring-program",
    "title": "CDC National Biomonitoring Program — National Exposure Report",
    "url": "https://www.cdc.gov/biomonitoring/resources/national-exposure-report.html"
  },
  "cf-bond-stability-forever-chemicals": {
    "bytes": 27091,
    "captured_at": "2026-07-03",
    "claim": "pfas: C-F bond among strongest -> forever chemicals",
    "confirming_quote": "one of the strongest in chemistry",
    "content_type": "html",
    "fetched_from": "https://www.colorado.edu/asmagazine/2024/12/20/breaking-bonds-forever-chemicals",
    "file": "receipts/sources/cf-bond-stability-forever-chemicals.htm",
    "inert": true,
    "raw_sha256": "85ab2e8829feb9b3feeb2be3fc72b4163665a11476a084cf5a250825da4881f0",
    "sha256": "f1032c6496021f6d8b37472322c014a7ce3d2dfb8838cf18c19e65b621700939",
    "slug": "cf-bond-stability-forever-chemicals",
    "title": "Breaking the bonds of forever chemicals (CU Boulder, 2024)",
    "url": "https://www.colorado.edu/asmagazine/2024/12/20/breaking-bonds-forever-chemicals"
  },
  "chen-2017-roads-dementia": {
    "bytes": 164161,
    "captured_at": "2026-06-09",
    "claim": "research/pm-alzheimers §3 ref [4] — living near major roads & dementia",
    "confirming_quote": "Living near major roads and the incidence of dementia, Parkinson's disease, and multiple sclerosis: a population-based cohort study",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/28063597/",
    "file": "receipts/sources/chen-2017-roads-dementia.htm",
    "inert": true,
    "raw_sha256": "7fe6e9d5bd44c26d9728c610a82904f39f2872b4953972890e16c01291fa5e68",
    "sha256": "778f891782aa699ed88d59caf677d0deb5cc6cf99b299c361bf9ea1721cf0df7",
    "slug": "chen-2017-roads-dementia",
    "title": "Chen et al. 2017, The Lancet — living near major roads & incidence of dementia (PMID 28063597)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/28063597/"
  },
  "epa-2023-cancer-alley-letter-of-concern": {
    "bytes": 45428,
    "captured_at": "2026-07-03",
    "claim": "pfas: EPA 2023 significant evidence of disparate impact",
    "confirming_quote": "disparate adverse impacts on Black residents",
    "content_type": "html",
    "fetched_from": "https://www.theregreview.org/2023/03/21/bruning-epa-finds-evidence-of-racial-discrimination-in-cancer-alley/",
    "file": "receipts/sources/epa-2023-cancer-alley-letter-of-concern.htm",
    "inert": true,
    "raw_sha256": "5d75ab2300b91060dd9d231fc624e2a7c30a9e3ba00c0e8e61c08de077a01996",
    "sha256": "be8ccea89a491fe51cd8e1a8139c0333aa9f232186aeee459ea0e284ab7f2e9c",
    "slug": "epa-2023-cancer-alley-letter-of-concern",
    "title": "EPA Letter of Concern, Cancer Alley Title VI (via The Regulatory Review, 2023)",
    "url": "https://www.theregreview.org/2023/03/21/bruning-epa-finds-evidence-of-racial-discrimination-in-cancer-alley/"
  },
  "epa-fy2022-superfund-population": {
    "bytes": 318983,
    "captured_at": "2026-07-03",
    "claim": "pfas EJ: ~50% (50.2%) minority/people-of-color within 1 mile of Superfund NPL sites (FY2022)",
    "confirming_quote": "50.2%",
    "content_type": "pdf",
    "fetched_from": "https://www.epa.gov/system/files/documents/2023-08/FY22%20Population%20Estimates%20Superfund%20Final.pdf",
    "file": "receipts/sources/epa-fy2022-superfund-population.pdf",
    "inert": false,
    "raw_sha256": "bb5a310989a7b10eec71bf3cc6cdc05a3ef24d9bda3e02d648e8bdc710e1851c",
    "sha256": "bb5a310989a7b10eec71bf3cc6cdc05a3ef24d9bda3e02d648e8bdc710e1851c",
    "slug": "epa-fy2022-superfund-population",
    "title": "Population Surrounding 1,881 Superfund Sites (EPA, FY2022)",
    "url": "https://www.epa.gov/system/files/documents/2023-08/FY22%20Population%20Estimates%20Superfund%20Final.pdf"
  },
  "frontiers-2025-louisiana-air-toxics": {
    "bytes": 366820,
    "captured_at": "2026-07-03",
    "claim": "pfas: LA 300+ mfg / 150+ petrochem / 15 refineries",
    "confirming_quote": "150 petrochemical plants",
    "content_type": "html",
    "fetched_from": "https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1601868/full",
    "file": "receipts/sources/frontiers-2025-louisiana-air-toxics.htm",
    "inert": true,
    "raw_sha256": "6a80ca6a59d78d78360c11fbec2cb8e87eafedcdcdddb23f831dac83b4445675",
    "sha256": "517449a259d126c86503972e8d36e1b9f12d43114ca4e7e59ef5f047f4a44ace",
    "slug": "frontiers-2025-louisiana-air-toxics",
    "title": "Air toxics and social vulnerability in Louisiana (Frontiers Public Health 2025)",
    "url": "https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1601868/full"
  },
  "grande-2020-cvd-airpollution-dementia": {
    "bytes": 172627,
    "captured_at": "2026-07-01",
    "claim": "research/pm-alzheimers §13 ref [3] — CVD/stroke mediation (~49%) of PM-dementia",
    "confirming_quote": "Association Between Cardiovascular Disease and Long-term Exposure to Air Pollution With the Risk of Dementia",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/32227140/",
    "file": "receipts/sources/grande-2020-cvd-airpollution-dementia.htm",
    "inert": true,
    "raw_sha256": "165f3a5fb9bb4b534f9e44e865f748e6e42f7911ac1522451e533d6ded6fc9bf",
    "sha256": "9aa1bac024f8524870debfda54ddec064a20e375969491a445fff912b6caa896",
    "slug": "grande-2020-cvd-airpollution-dementia",
    "title": "Grande et al. 2020, JAMA Neurology — CVD & long-term air pollution with dementia risk (PMID 32227140)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/32227140/"
  },
  "hrw-2024-were-dying-here": {
    "bytes": 388329,
    "captured_at": "2026-07-03",
    "claim": "pfas: 85-mi corridor, ~200 facilities (Cancer Alley)",
    "confirming_quote": "200 fossil fuel and petrochemical operations",
    "content_type": "html",
    "fetched_from": "https://www.hrw.org/report/2024/01/25/were-dying-here/fight-life-louisiana-fossil-fuel-sacrifice-zone",
    "file": "receipts/sources/hrw-2024-were-dying-here.htm",
    "inert": true,
    "raw_sha256": "48f75a7c8ce565644e8701fe1e33210d2a928b569ec09c617aee3b81b10646b1",
    "sha256": "502fa83b607ff20f9c6f8a508e8b9463dd811f570d09bb9a58de50fcdf5327d6",
    "slug": "hrw-2024-were-dying-here",
    "title": "We're Dying Here (Human Rights Watch, 2024)",
    "url": "https://www.hrw.org/report/2024/01/25/were-dying-here/fight-life-louisiana-fossil-fuel-sacrifice-zone"
  },
  "huang-2025-pm25-dementia-burden-of-proof": {
    "bytes": 614700,
    "captured_at": "2026-06-09",
    "claim": "research/pm-alzheimers-full §6 ref [12]",
    "confirming_quote": "PM2.5 and all-cause dementia ... weak and inconsistent",
    "fetched_from": "https://doi.org/10.1038/s43587-025-00844-y",
    "file": "receipts/sources/huang-2025-pm25-dementia-burden-of-proof.htm",
    "inert": true,
    "raw_sha256": "3f697a1010a9c256561adfc70086539f296bd68c38d67fe80c99ef54ac298cfb",
    "sha256": "4a08f1e630e79509fe18d8fb7ef3ec23b0bca7e48765be35429f4782a1c2f658",
    "slug": "huang-2025-pm25-dementia-burden-of-proof",
    "title": "Huang et al. 2025, Nature Aging — Burden of Proof PM2.5→dementia meta-analysis",
    "url": "https://doi.org/10.1038/s43587-025-00844-y"
  },
  "klepeis-2001-nhaps": {
    "bytes": 325779,
    "captured_at": "2026-06-09",
    "claim": "research/pm-alzheimers-full §2 ref [6] (~87% time indoors)",
    "confirming_quote": "National Human Activity Pattern Survey (NHAPS): a resource for assessing exposure to environmental pollutants",
    "fetched_from": "https://doi.org/10.1038/sj.jea.7500165",
    "file": "receipts/sources/klepeis-2001-nhaps.htm",
    "inert": true,
    "raw_sha256": "5b5b3e4ea7e8a4357d9083327f3b2bdfb9efa23091bb7a57b063f6ed327b44cb",
    "sha256": "5b4c8c297c258c94f1e459bdf23d2c424862bb17d31fc0b68e3a628631dcccda",
    "slug": "klepeis-2001-nhaps",
    "title": "Klepeis et al. 2001, J Exposure Sci Environ Epidemiol — NHAPS",
    "url": "https://doi.org/10.1038/sj.jea.7500165"
  },
  "lancet-ph-2025-pm-dementia-meta": {
    "bytes": 145160,
    "captured_at": "2026-06-09",
    "claim": "research/pm-alzheimers §3 ref [5] — headline pooled HR 1.08 per 5 µg/m³",
    "confirming_quote": "Long-term air pollution exposure and incident dementia: a systematic review and meta-analysis",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/40716448/",
    "file": "receipts/sources/lancet-ph-2025-pm-dementia-meta.htm",
    "inert": true,
    "raw_sha256": "0245eaa10680341bade5c32826b2eaedf361cc8196883cb5429982c5efa26257",
    "sha256": "9181007b36fd0a91d087622d92cd3011d55d14eb6fa7b999d34b0a0d2d5198d4",
    "slug": "lancet-ph-2025-pm-dementia-meta",
    "title": "Lancet Planetary Health 2025 — long-term air pollution & incident dementia meta-analysis (PMID 40716448)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/40716448/"
  },
  "livingston-2020-lancet-commission": {
    "bytes": 223871,
    "captured_at": "2026-06-09",
    "claim": "research/pm-alzheimers §1 ref [8] — 2020 Lancet Commission added air pollution to modifiable risks",
    "confirming_quote": "Dementia prevention, intervention, and care: 2020 report of the Lancet Commission",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/32738937/",
    "file": "receipts/sources/livingston-2020-lancet-commission.htm",
    "inert": true,
    "raw_sha256": "02c311ebd3b1732b59bcd5caa844c8c9960abb2719e88d0e616602a4bb798dfe",
    "sha256": "9b9839543c8211a5993ae3a24ac5a150bb9ab5e5a019a0d8841bb82227802036",
    "slug": "livingston-2020-lancet-commission",
    "title": "Livingston et al. 2020, The Lancet — Dementia prevention 2020 Lancet Commission report (PMID 32738937)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/32738937/"
  },
  "maher-2016-magnetite-brain-nanoparticles": {
    "bytes": 196206,
    "captured_at": "2026-07-01",
    "claim": "research/pm-alzheimers §13 ref [11] — magnetite pollution nanoparticles in the human brain",
    "confirming_quote": "Magnetite pollution nanoparticles in the human brain",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/27601646/",
    "file": "receipts/sources/maher-2016-magnetite-brain-nanoparticles.htm",
    "inert": true,
    "raw_sha256": "d3ae631422a4936bd0f469d3688afa0721e74a1185161f306595ef4472a14ed0",
    "sha256": "4e3e4cd6cab77eae1e0acdd730f9ed28b96d251129f057de7fc351616a0fd36f",
    "slug": "maher-2016-magnetite-brain-nanoparticles",
    "title": "Maher et al. 2016, PNAS — magnetite pollution nanoparticles in the human brain (PMID 27601646)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/27601646/"
  },
  "mohai-2009-proximity-ajph": {
    "bytes": 174475,
    "captured_at": "2026-07-03",
    "claim": "pfas EJ: 38.1% Black vs 28.4% white within 1mi; OR 1.38",
    "confirming_quote": "28.4% of White respondents",
    "content_type": "html",
    "fetched_from": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2774179/",
    "file": "receipts/sources/mohai-2009-proximity-ajph.htm",
    "inert": true,
    "raw_sha256": "8fa51f0af2b85c9b265d1496e135b2cff9b4b258b076c06d854de6bb11408c07",
    "sha256": "15276da028d0dc4eaa34c3078073e414c6c2449b6e74fea458f13db5bc157d8f",
    "slug": "mohai-2009-proximity-ajph",
    "title": "Mohai et al., Racial/Socioeconomic Disparities in Proximity to Polluting Facilities (AJPH 2009)",
    "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2774179/"
  },
  "nhanes-pfas-1999-2020-envres": {
    "bytes": 223575,
    "captured_at": "2026-07-03",
    "claim": "pfas: PFHpS highest weighted detection 78.2%",
    "confirming_quote": "highest for PFHpS",
    "content_type": "html",
    "fetched_from": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12082571/",
    "file": "receipts/sources/nhanes-pfas-1999-2020-envres.htm",
    "inert": true,
    "raw_sha256": "5dfbdd6c85dc28a7d7c796ef486fdc05d92df07392789c28a5780a41c3b1e7e3",
    "sha256": "cc5170a945f11466ab2bdc6595a9f24801b65be7d9c3104f6fbdcd13945b18cb",
    "slug": "nhanes-pfas-1999-2020-envres",
    "title": "PFAS exposure NHANES 1999-March 2020 (Environmental Research 2025)",
    "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12082571/"
  },
  "oberdorster-2004-ultrafine-particle-brain-translocation": {
    "bytes": 140640,
    "captured_at": "2026-07-01",
    "claim": "research/pm-alzheimers §13 ref [10] — ultrafine particle brain translocation via olfactory nerve",
    "confirming_quote": "Translocation of inhaled ultrafine particles to the brain",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/15204759/",
    "file": "receipts/sources/oberdorster-2004-ultrafine-particle-brain-translocation.htm",
    "inert": true,
    "raw_sha256": "130a7d6d4e82ba4dbf91f8499dcc1b25a953aa2910e82769a4efe2b8769ffc04",
    "sha256": "6cc7d489d21f463a8eb726111b192dbf55b14d62e94f13b365b3272e8fb41a4c",
    "slug": "oberdorster-2004-ultrafine-particle-brain-translocation",
    "title": "Oberdörster et al. 2004, Inhalation Toxicology — translocation of inhaled ultrafine particles to the brain (PMID 15204759)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/15204759/"
  },
  "robinson-2025-pnas-cancer-alley": {
    "bytes": 335964,
    "captured_at": "2026-07-03",
    "claim": "pfas: 12% land/45% TRI/57% emissions; up to 11.6x EPA; EtO+chloroprene+formaldehyde 63-96.9%",
    "confirming_quote": "57% of mass emissions from TRI",
    "content_type": "html",
    "fetched_from": "http://web.archive.org/web/20260430063804/https://www.pnas.org/doi/10.1073/pnas.2504770122",
    "file": "receipts/sources/robinson-2025-pnas-cancer-alley.htm",
    "inert": true,
    "raw_sha256": "fe13d79fe910af18bb059e1af0585e34e39a0bf2bc703b94420c36c1305f8613",
    "sha256": "9f601ee8cb57c53a2869edbb735373cf12c02e75be7e6112a859c9b6c30c6c41",
    "slug": "robinson-2025-pnas-cancer-alley",
    "title": "Robinson et al., measured air pollution & disparate cancer risk in Louisiana (PNAS 2025)",
    "url": "https://www.pnas.org/doi/10.1073/pnas.2504770122"
  },
  "sahu-2021-pm-app-ps1-amyloid": {
    "bytes": 193706,
    "captured_at": "2026-07-01",
    "claim": "research/pm-alzheimers §13 ref [7] — PM exacerbates Aβ plaque & gliosis (APP/PS1 mice)",
    "confirming_quote": "Particulate Matter Exposure Exacerbates Amyloid-β Plaque Deposition and Gliosis in APP/PS1 Mice",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/33554902/",
    "file": "receipts/sources/sahu-2021-pm-app-ps1-amyloid.htm",
    "inert": true,
    "raw_sha256": "190932234e62de72d4d93070fb60b4033133d9afb605ddb706d8b8b940e44be7",
    "sha256": "0218fded006ac44f560101fbc0cc1b908985c3b820770dca94f1beb30bd1d18e",
    "slug": "sahu-2021-pm-app-ps1-amyloid",
    "title": "Sahu et al. 2021, J Alzheimer's Disease — PM2.5 exacerbates Aβ plaque & gliosis in APP/PS1 mice (PMID 33554902)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/33554902/"
  },
  "shi-2020-medicare-pm25-dementia": {
    "bytes": 204291,
    "captured_at": "2026-06-09",
    "claim": "research/pm-alzheimers §3 ref [2] — US Medicare PM2.5 cohort",
    "confirming_quote": "Long-term effects of PM2.5 on neurological disorders in the American Medicare population: a longitudinal cohort study",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/33091388/",
    "file": "receipts/sources/shi-2020-medicare-pm25-dementia.htm",
    "inert": true,
    "raw_sha256": "0dea97d36089d5ebfd85742da1031d593a590400b5156772ee554329fd349667",
    "sha256": "69bcd0531e15c31c65260f045347a66100d1688c1c1e2f57a9da112db8149f52",
    "slug": "shi-2020-medicare-pm25-dementia",
    "title": "Shi et al. 2020, Lancet Planetary Health — PM2.5 & neurological disorders, Medicare (PMID 33091388)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/33091388/"
  },
  "wilker-2023-bmj-airpollution-dementia": {
    "bytes": 157394,
    "captured_at": "2026-07-01",
    "claim": "research/pm-alzheimers §13 ref [9] — BMJ meta-analysis — null overall HR (heterogeneous)",
    "confirming_quote": "Ambient air pollution and clinical dementia: systematic review and meta-analysis",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/37019461/",
    "file": "receipts/sources/wilker-2023-bmj-airpollution-dementia.htm",
    "inert": true,
    "raw_sha256": "449cc0bb8cb4cf23da9e08efa0f3605a1e51e972a916e51ea65a1bcefc1f5665",
    "sha256": "aeb57dd14b2fb3bbcfe95baaf8434bd4b1a168192bc43d5d566e5d746797c424",
    "slug": "wilker-2023-bmj-airpollution-dementia",
    "title": "Wilker et al. 2023, BMJ — ambient air pollution & clinical dementia meta-analysis (PMID 37019461)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/37019461/"
  },
  "schwabl-2019-microplastics-human-stool": {
    "bytes": 130099,
    "captured_at": "2026-06-10",
    "claim": "microplastics RoR: schwabl-2019-microplastics-human-stool",
    "confirming_quote": "Detection of Various Microplastics in Human Stool",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/31476765/",
    "file": "receipts/sources/schwabl-2019-microplastics-human-stool.htm",
    "inert": true,
    "raw_sha256": "72791ab356362dcdb4f038f8911c7d49abf50dd6ed039a96be562914a6febf54",
    "sha256": "03aeb4cfb7673fec7e5ca057b7809a5dfecf6da7bd66f810b9aac1065cbf02f4",
    "slug": "schwabl-2019-microplastics-human-stool",
    "title": "Schwabl et al., Detection of Various Microplastics in Human Stool (Annals of Internal Medicine 2019)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/31476765/"
  },
  "leslie-2022-microplastics-human-blood": {
    "bytes": 133103,
    "captured_at": "2026-06-10",
    "claim": "microplastics RoR: leslie-2022-microplastics-human-blood",
    "confirming_quote": "Discovery and quantification of plastic particle pollution in human blood",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/35367073/",
    "file": "receipts/sources/leslie-2022-microplastics-human-blood.htm",
    "inert": true,
    "raw_sha256": "e1c3b746f22a44858fed63961e7b6420c7c40f9fd62619e633ad0c65fa8fb8c6",
    "sha256": "5eeffa7dfce69170884334225b04a16040b87159393532f3312ccd9e9a581f58",
    "slug": "leslie-2022-microplastics-human-blood",
    "title": "Leslie et al., Discovery and quantification of plastic particle pollution in human blood (Environment International 2022)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/35367073/"
  },
  "ragusa-2021-microplastics-human-placenta": {
    "bytes": 145916,
    "captured_at": "2026-06-10",
    "claim": "microplastics RoR: ragusa-2021-microplastics-human-placenta",
    "confirming_quote": "Plasticenta: First evidence of microplastics in human placenta",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/33395930/",
    "file": "receipts/sources/ragusa-2021-microplastics-human-placenta.htm",
    "inert": true,
    "raw_sha256": "f3f4b86a7b666d8d2eaee9506bac27b3c8926d24702ea8512f7506674303b8d7",
    "sha256": "09e8ee1674939938be1ba4d1dd1669576bec2adba738fbfed40ceb63253b02e8",
    "slug": "ragusa-2021-microplastics-human-placenta",
    "title": "Ragusa et al., Plasticenta: First evidence of microplastics in human placenta (Environment International 2021)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/33395930/"
  },
  "cox-2019-human-consumption-microplastics": {
    "bytes": 128154,
    "captured_at": "2026-07-02",
    "claim": "microplastics RoR: cox-2019-human-consumption-microplastics",
    "confirming_quote": "Human Consumption of Microplastics",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/31184127/",
    "file": "receipts/sources/cox-2019-human-consumption-microplastics.htm",
    "inert": true,
    "raw_sha256": "060a6aee9940dbbdbab38739b64ffb7938c8d969dd5f475fffc44ca921575211",
    "sha256": "6c12597c517125f5cd55d404f5e7cec16a207e7a6e88fd2fad120a01339262a6",
    "slug": "cox-2019-human-consumption-microplastics",
    "title": "Cox et al., Human Consumption of Microplastics (Environmental Science & Technology 2019)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/31184127/"
  },
  "who-2019-microplastics-drinking-water": {
    "bytes": 81054,
    "captured_at": "2026-07-02",
    "claim": "microplastics RoR: who-2019-microplastics-drinking-water",
    "confirming_quote": "Based on the limited information we have, microplastics in drinking water don’t appear to pose a health risk at current levels.",
    "content_type": "html",
    "fetched_from": "https://www.who.int/news/item/22-08-2019-who-calls-for-more-research-into-microplastics-and-a-crackdown-on-plastic-pollution",
    "file": "receipts/sources/who-2019-microplastics-drinking-water.htm",
    "inert": true,
    "raw_sha256": "28541b57624057a94038f0e5688ce0aeefdb379019ab9b1050d20999d3d4efc2",
    "sha256": "ddce4c63e301f27b43cd68b581f914488eab11bfd90d690a1b2d26ffa54c2baf",
    "slug": "who-2019-microplastics-drinking-water",
    "title": "World Health Organization, Microplastics in drinking-water (WHO 2019)",
    "url": "https://www.who.int/news/item/22-08-2019-who-calls-for-more-research-into-microplastics-and-a-crackdown-on-plastic-pollution"
  },
  "yong-2020-toxicity-micro-nanoplastics-mammalian": {
    "bytes": 148656,
    "captured_at": "2026-07-02",
    "claim": "microplastics RoR: yong-2020-toxicity-micro-nanoplastics-mammalian",
    "confirming_quote": "Toxicity of Microplastics and Nanoplastics in Mammalian Systems",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/32111046/",
    "file": "receipts/sources/yong-2020-toxicity-micro-nanoplastics-mammalian.htm",
    "inert": true,
    "raw_sha256": "c866be80c18c5e57f65ab8a3c407704234c83f43fbe0a2fc67aabe79490fba28",
    "sha256": "f8fc159d719b434bbb8ccf846bf5def5f506da5921af29dca23d556f47ae8cca",
    "slug": "yong-2020-toxicity-micro-nanoplastics-mammalian",
    "title": "Yong et al., Toxicity of Microplastics and Nanoplastics in Mammalian Systems (IJERPH 2020)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/32111046/"
  },
  "wright-kelly-2017-plastic-human-health": {
    "bytes": 119446,
    "captured_at": "2026-07-02",
    "claim": "microplastics RoR: wright-kelly-2017-plastic-human-health",
    "confirming_quote": "Plastic and Human Health: A Micro Issue?",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/28531345/",
    "file": "receipts/sources/wright-kelly-2017-plastic-human-health.htm",
    "inert": true,
    "raw_sha256": "cdedcc65f570715b20d7ed64c184e8ed9c3de0747b8bab57dd9b276d214e9b43",
    "sha256": "1ef4b9f64945560dfbaca3e4e17e295bbe5db11a3f59bb93f022759f666ed293",
    "slug": "wright-kelly-2017-plastic-human-health",
    "title": "Wright & Kelly, Plastic and Human Health: A Micro Issue? (Environmental Science & Technology 2017)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/28531345/"
  },
  "vethaak-legler-2021-microplastics-human-health": {
    "bytes": 126027,
    "captured_at": "2026-07-02",
    "claim": "microplastics RoR: vethaak-legler-2021-microplastics-human-health",
    "confirming_quote": "Microplastics and human health",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/33574197/",
    "file": "receipts/sources/vethaak-legler-2021-microplastics-human-health.htm",
    "inert": true,
    "raw_sha256": "642746f1d8f4e4b1144eaab18092c2a9e4250dca8cca15cab334694187eab480",
    "sha256": "cc513797eeb4da009fcf3549b4debfa25c84cd501405267da2dc861d941d243e",
    "slug": "vethaak-legler-2021-microplastics-human-health",
    "title": "Vethaak & Legler, Microplastics and human health (Science 2021)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/33574197/"
  },
  "owen-2010-brain-training-nature": {
    "bytes": 172540,
    "captured_at": "2026-07-04",
    "claim": "cog-training: large trained-task gains but no transfer to untrained cognition, even closely related tasks",
    "confirming_quote": "even when those tasks were cognitively closely related",
    "content_type": "html",
    "fetched_from": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2884087/",
    "file": "receipts/sources/owen-2010-brain-training-nature.htm",
    "inert": true,
    "raw_sha256": "c9da9f05cefd77fe089ca11f42e1c30867e6d22fc97dd789565e1d9305e2d9d1",
    "sha256": "c5a120a92123de068cb80446c27697d6fc1222983bf3873b45daabe78b40f944",
    "slug": "owen-2010-brain-training-nature",
    "title": "Owen et al. 2010, Nature — Putting brain training to the test (PMID 20407435)",
    "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2884087/"
  },
  "simons-2016-brain-training-pspi": {
    "bytes": 116233,
    "captured_at": "2026-07-04",
    "claim": "cog-training: extensive evidence for trained-task gains, little evidence for distant transfer/everyday cognition",
    "confirming_quote": "little evidence that training enhances performance on distantly related tasks",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/27697851/",
    "file": "receipts/sources/simons-2016-brain-training-pspi.htm",
    "inert": true,
    "raw_sha256": "b8f48afd1358cbbb7d18b8d64136a3d8c91e6f1d0a61bc9035b86221319b5d74",
    "sha256": "c06ea756698f593ff1b31b8be5bba2c73ea092e3ab680ad092584e4cfc482458",
    "slug": "simons-2016-brain-training-pspi",
    "title": "Simons et al. 2016, Psychological Science in the Public Interest — Do 'Brain-Training' Programs Work? (PMID 27697851)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/27697851/"
  },
  "melby-lervag-2013-wm-training": {
    "bytes": 117635,
    "captured_at": "2026-07-04",
    "claim": "cog-training: WM training produces short-term specific effects that do not generalize",
    "confirming_quote": "short-term, specific training effects that do not generalize",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/22612437/",
    "file": "receipts/sources/melby-lervag-2013-wm-training.htm",
    "inert": true,
    "raw_sha256": "994a5c59bc3e06e2c9a685b4275273dba7f28f6e12f4c2e81f70008e3374f210",
    "sha256": "3cec252f0deba156faadbece7ab3347327774561658e53c41e629aadbbf6d743",
    "slug": "melby-lervag-2013-wm-training",
    "title": "Melby-Lervag & Hulme 2013, Developmental Psychology — Is working memory training effective? (PMID 22612437)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/22612437/"
  },
  "melby-lervag-2016-far-transfer": {
    "bytes": 406646,
    "captured_at": "2026-07-04",
    "claim": "cog-training: no convincing far transfer from WM training against treated controls",
    "confirming_quote": "no convincing evidence of any reliable improvements",
    "content_type": "html",
    "fetched_from": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4968033/",
    "file": "receipts/sources/melby-lervag-2016-far-transfer.htm",
    "inert": true,
    "raw_sha256": "10df32621efbe0e7c3ef78ae2cf80dcc40f0d05bddf66936bc7b0ff25f5d3071",
    "sha256": "4d994812b3ed3eb68dd92e6e9c0b19eb19e03f3d4ed02a4d455b780fa6ea1121",
    "slug": "melby-lervag-2016-far-transfer",
    "title": "Melby-Lervag, Redick & Hulme 2016, Perspectives on Psychological Science — no far transfer from WM training (PMC4968033)",
    "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4968033/"
  },
  "stanford-maxplanck-2014-consensus": {
    "bytes": 106013,
    "captured_at": "2026-07-04",
    "claim": "cog-training: 2014 scientist consensus objecting to brain-training claims (no compelling evidence)",
    "confirming_quote": "no compelling scientific evidence to date that they do",
    "content_type": "html",
    "fetched_from": "https://longevity.stanford.edu/a-consensus-on-the-brain-training-industry-from-the-scientific-community-2/",
    "file": "receipts/sources/stanford-maxplanck-2014-consensus.htm",
    "inert": true,
    "raw_sha256": "8103ee7b423476cae32269fd5326c4094703f01e0dd8fb407a539076feb537e5",
    "sha256": "6ed7bacbc442507c4df4ecddb3069f7bf543d5cf98788bb7886697a11584d2e2",
    "slug": "stanford-maxplanck-2014-consensus",
    "title": "Stanford Center on Longevity & Max Planck Institute 2014 — A Consensus on the Brain Training Industry",
    "url": "https://longevity.stanford.edu/a-consensus-on-the-brain-training-industry-from-the-scientific-community-2/"
  },
  "cognitive-training-data-2014-response": {
    "bytes": 30106,
    "captured_at": "2026-07-04",
    "claim": "cog-training: 2014 industry-aligned rebuttal claiming training can significantly improve cognition",
    "confirming_quote": "significantly improve cognitive function",
    "content_type": "html",
    "fetched_from": "https://www.cognitivetrainingdata.org/the-controversy-does-brain-training-work/response-letter/",
    "file": "receipts/sources/cognitive-training-data-2014-response.htm",
    "inert": true,
    "raw_sha256": "304a4718f116c76efe4211e1bfd25f595be119ab05130b57fca65ad8b950345c",
    "sha256": "f5a09bf115104650f04cb62550335ad0b281b8186204430b223c12771f430fb8",
    "slug": "cognitive-training-data-2014-response",
    "title": "Cognitive Training Data 2014 — Response to the 'Consensus on the Brain Training Industry' statement",
    "url": "https://www.cognitivetrainingdata.org/the-controversy-does-brain-training-work/response-letter/"
  },
  "ftc-2016-lumosity-settlement": {
    "bytes": 988128,
    "captured_at": "2026-07-04",
    "claim": "cog-training: FTC settled deceptive-advertising charges against Lumosity's brain-training claims",
    "confirming_quote": "did not have the science to back up its ads",
    "content_type": "html",
    "fetched_from": "https://www.ftc.gov/news-events/news/press-releases/2016/01/lumosity-pay-2-million-settle-ftc-deceptive-advertising-charges-its-brain-training-program",
    "file": "receipts/sources/ftc-2016-lumosity-settlement.htm",
    "inert": true,
    "raw_sha256": "8ec9d0ef7bcb938bf3062356d2b8dc35cc2b5554f9e76212caa9525e48771f7f",
    "sha256": "1d6f819857270bc85f0bf445ce0f4e09205d23ce0162e1fa5f63becdfa589caf",
    "slug": "ftc-2016-lumosity-settlement",
    "title": "U.S. Federal Trade Commission 2016 — Lumosity to Pay $2 Million to Settle FTC Deceptive Advertising Charges (matter 132-3212)",
    "url": "https://www.ftc.gov/news-events/news/press-releases/2016/01/lumosity-pay-2-million-settle-ftc-deceptive-advertising-charges-its-brain-training-program"
  },
  "ball-2002-active-jama": {
    "bytes": 266139,
    "captured_at": "2026-07-04",
    "claim": "cog-training: ACTIVE each intervention improved its targeted ability, durable to 2 years",
    "confirming_quote": "Each intervention improved the targeted cognitive ability compared with baseline",
    "content_type": "html",
    "fetched_from": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2916176/",
    "file": "receipts/sources/ball-2002-active-jama.htm",
    "inert": true,
    "raw_sha256": "e33246299c66ed4362ebf413c5629a3679dfc4bf281db34eca7b57e0e239da2d",
    "sha256": "42ff8b7e953ca00e2ba51e38b1f897420f9a8e6b2c32dce66efdb448f65b8a9e",
    "slug": "ball-2002-active-jama",
    "title": "Ball et al. 2002, JAMA — ACTIVE cognitive training RCT in older adults (PMID 12425704)",
    "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2916176/"
  },
  "rebok-2014-active-10yr": {
    "bytes": 226650,
    "captured_at": "2026-07-04",
    "claim": "cog-training: ACTIVE 10-year everyday-function benefit was self-reported (IADL)",
    "confirming_quote": "at or above their baseline level of self-reported IADL function at 10 years",
    "content_type": "html",
    "fetched_from": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4055506/",
    "file": "receipts/sources/rebok-2014-active-10yr.htm",
    "inert": true,
    "raw_sha256": "b143d7c29e1e61ba2963beb34b87cdb07e2b8ae058d5b4cfe92c6efe1f037d7f",
    "sha256": "66c8a573bd383c458ef095630b98ffd841ae6647316294e164c526f8862f29ab",
    "slug": "rebok-2014-active-10yr",
    "title": "Rebok et al. 2014, J Am Geriatr Soc — Ten-Year Effects of the ACTIVE Cognitive Training Trial (PMID 24417410)",
    "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4055506/"
  },
  "edwards-2017-speed-dementia": {
    "bytes": 193744,
    "captured_at": "2026-07-04",
    "claim": "cog-training: contested speed-training dementia-risk signal HR 0.71, statistically borderline",
    "confirming_quote": "The hazard of dementia was 29% lower for speed training than control",
    "content_type": "html",
    "fetched_from": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5700828/",
    "file": "receipts/sources/edwards-2017-speed-dementia.htm",
    "inert": true,
    "raw_sha256": "7eecafafd48735640f32bcf12da11fea2403c180faf38fe6c98705ec36440f4c",
    "sha256": "3d6dd1b57c4ca964bdd41c1c88fa7fd4fdd08ab4cd19ea1ca4a55dbacf953ca2",
    "slug": "edwards-2017-speed-dementia",
    "title": "Edwards et al. 2017, Alzheimer's & Dementia TRCI — Speed of processing training and lower dementia risk (PMID 29201994)",
    "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5700828/"
  },
  "hausknecht-2007-retest-meta": {
    "bytes": 111382,
    "captured_at": "2026-07-04",
    "claim": "cog-training: retest/practice effects raise scores without ability change (107 samples, 134,436 participants)",
    "confirming_quote": "Results from 107 samples and 134,436 participants",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/17371085/",
    "file": "receipts/sources/hausknecht-2007-retest-meta.htm",
    "inert": true,
    "raw_sha256": "350accc2a734117a66e09628e2434c3a5cb00c55cd3b418a3901c0b984d3b4de",
    "sha256": "c2fa84c917533f1f535813013f9d80ec5c68c1775d7f4d145cfcc689d3939cb7",
    "slug": "hausknecht-2007-retest-meta",
    "title": "Hausknecht et al. 2007, Journal of Applied Psychology — Retesting: meta-analysis of coaching & practice effects (PMID 17371085)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/17371085/"
  },
  "gray-2015-act-anticholinergic-dementia": {
    "bytes": 193704,
    "captured_at": "2026-07-07",
    "claim": "anticholinergic §2.1 ref[1] Gray 2015 ACT HR 1.54",
    "confirming_quote": "1.54 (95% CI, 1.21-1.96) for TSDDs greater than 1095",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/25621434/",
    "file": "receipts/sources/gray-2015-act-anticholinergic-dementia.htm",
    "inert": true,
    "raw_sha256": "ebfd2da9b6b067ee6706e2af3afeca911d70f69db967ec167b1b811ad0923dd6",
    "sha256": "0137ea7ee73e40b4a754892b79bd126a5951d8d0a264c07e4b936d05a270bf86",
    "slug": "gray-2015-act-anticholinergic-dementia",
    "title": "Gray et al. 2015, JAMA Intern Med — Cumulative strong anticholinergics & incident dementia (ACT cohort, HR 1.54)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/25621434/"
  },
  "coupland-2019-qresearch-anticholinergic-dementia": {
    "bytes": 126545,
    "captured_at": "2026-07-07",
    "claim": "anticholinergic §2.1 ref[2] Coupland 2019 QResearch OR 1.49",
    "confirming_quote": "1.06 (95% CI, 1.03-1.09) in the lowest overall anticholinergic exposure category (total exposure of 1-90 TSDDs) to 1.49 (95% CI, 1.44-1.54) in the highest",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/31233095/",
    "file": "receipts/sources/coupland-2019-qresearch-anticholinergic-dementia.htm",
    "inert": true,
    "raw_sha256": "46b5d2c2a8135b51a91ccc12d06265b39057f45969db38f12206b07e84dd314f",
    "sha256": "cba10f28bce06679776067bb95f23d1bd38baac767f9effa5917ed2dbfac9355",
    "slug": "coupland-2019-qresearch-anticholinergic-dementia",
    "title": "Coupland et al. 2019, JAMA Intern Med — Anticholinergic drug exposure & risk of dementia (QResearch, OR 1.49)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/31233095/"
  },
  "richardson-2018-cprd-anticholinergic-dementia": {
    "bytes": 182838,
    "captured_at": "2026-07-07",
    "claim": "anticholinergic §2.1 ref[3] Richardson 2018 CPRD OR 1.11",
    "confirming_quote": "Anticholinergic drugs and risk of dementia: case-control study",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/29695481/",
    "file": "receipts/sources/richardson-2018-cprd-anticholinergic-dementia.htm",
    "inert": true,
    "raw_sha256": "5c0d9b6b4626cea2b98548af1849c9261bfe9b22dd68a06ea91167932e20e057",
    "sha256": "2fc70e5e2d5297b22bea0f818d9e014c68f11faf66324d90aa35326e30efb499",
    "slug": "richardson-2018-cprd-anticholinergic-dementia",
    "title": "Richardson et al. 2018, BMJ — Anticholinergic drugs & risk of dementia (CPRD case-control)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/29695481/"
  },
  "carriere-2009-3city-anticholinergic-dementia": {
    "bytes": 143175,
    "captured_at": "2026-07-07",
    "claim": "anticholinergic §2.4 ref[4] Carriere 2009 3-City HR 1.65",
    "confirming_quote": "Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/19636034/",
    "file": "receipts/sources/carriere-2009-3city-anticholinergic-dementia.htm",
    "inert": true,
    "raw_sha256": "a7bd794b05c1e3cd11c4d0f5800a99935573e1d578c7d253ef0525025181d997",
    "sha256": "e6af9a55f5c2d1e4b122fa0d12443543edbdeebb3d0f1dc1cccda188369b57b3",
    "slug": "carriere-2009-3city-anticholinergic-dementia",
    "title": "Carrière et al. 2009, Arch Intern Med — Anticholinergic drugs, cognitive decline & dementia (3-City study)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/19636034/"
  },
  "liu-2020-taiwan-anticholinergic-potency-dementia": {
    "bytes": 128697,
    "captured_at": "2026-07-07",
    "claim": "anticholinergic §2.4 ref[9] Liu 2020 Taiwan null HR 1.043",
    "confirming_quote": "Are Anticholinergic Medications Associated With Increased Risk of Dementia and Behavioral and Psychological Symptoms of Dementia? A Nationwide 15-Year Follow-Up Cohort Study in Taiwan",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/32116707/",
    "file": "receipts/sources/liu-2020-taiwan-anticholinergic-potency-dementia.htm",
    "inert": true,
    "raw_sha256": "d6907fcd6ce8b4fce7d8f3dd3b4f5da5ced355b7f088905a10a54a8650b8641f",
    "sha256": "0dbf1f0fd325194510a84731bfd77f8f90a5556683e63fb56cf9ef7a76f862dc",
    "slug": "liu-2020-taiwan-anticholinergic-potency-dementia",
    "title": "Liu et al. 2020, Front Pharmacol — Anticholinergics & dementia risk, Taiwan 15-yr cohort (null HR 1.043)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/32116707/"
  },
  "hafdi-2019-prediva-anticholinergic-dementia": {
    "bytes": 132790,
    "captured_at": "2026-07-07",
    "claim": "anticholinergic §2.4 ref[7] Hafdi 2019 preDIVA confounding-by-indication",
    "confirming_quote": "Association of Benzodiazepine and Anticholinergic Drug Usage With Incident Dementia: A Prospective Cohort Study of Community-Dwelling Older Adults",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/31300339/",
    "file": "receipts/sources/hafdi-2019-prediva-anticholinergic-dementia.htm",
    "inert": true,
    "raw_sha256": "25e2d6ac29d58e42a13df3a795c38c31114a57ab66b7f9a4eea0a99096b935bf",
    "sha256": "b7d03e24c06c5c512b1aa06be48bcfefecba1eab541f07964161a3b433433f0c",
    "slug": "hafdi-2019-prediva-anticholinergic-dementia",
    "title": "Hafdi et al. 2020, JAMDA — Benzodiazepine & anticholinergic usage with incident dementia (preDIVA)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/31300339/"
  },
  "matta-2021-ontario-oab-dementia": {
    "bytes": 167334,
    "captured_at": "2026-07-07",
    "claim": "anticholinergic §2.3 ref[18] Matta 2021 Ontario OAB",
    "confirming_quote": "Receipt of Overactive Bladder Drugs and Incident Dementia",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/34742663/",
    "file": "receipts/sources/matta-2021-ontario-oab-dementia.htm",
    "inert": true,
    "raw_sha256": "93aea008569b1bae6c9b9995963d5cc8d2892e13a1fa31e2c01a013b450e0745",
    "sha256": "54e6ef0cc6ca59c6bd222ea4ad336438209bc4154e9a527ff0f38ebbaec30490",
    "slug": "matta-2021-ontario-oab-dementia",
    "title": "Matta et al. 2022, Eur Urol Focus — Receipt of overactive bladder drugs & incident dementia (Ontario)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/34742663/"
  },
  "park-2024-korea-oab-mirabegron-dementia": {
    "bytes": 165210,
    "captured_at": "2026-07-07",
    "claim": "anticholinergic §2.3 ref[17] Park 2024 Korea aHR 1.213",
    "confirming_quote": "Risks of Dementia After Treatment with an Anticholinergic, Beta-3 Agonist, or Combination of Both for an Overactive Bladder: A Korean National Cohort Study",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/38388215/",
    "file": "receipts/sources/park-2024-korea-oab-mirabegron-dementia.htm",
    "inert": true,
    "raw_sha256": "e98bcd139bb1e01a35bb31cfb0c71128f481954151cfb3566dd96b2c47d803db",
    "sha256": "eda4ced56055bf6968d328e97494f9e8de97af129b7cb3aaa2ab7aae5e26e0e3",
    "slug": "park-2024-korea-oab-mirabegron-dementia",
    "title": "Park et al. 2024, Eur Urol Focus — Dementia risk after anticholinergic/beta-3/combination OAB treatment (Korea, aHR 1.213)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/38388215/"
  },
  "asiimwe-2025-ukb-allofus-acmi-dementia": {
    "bytes": 175197,
    "captured_at": "2026-07-07",
    "claim": "anticholinergic §2.2 ref[16] Asiimwe 2025 UKB HR 1.15",
    "confirming_quote": "The anticholinergic medication index and dementia risk: evidence from the UK Biobank and All of Us research program",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/41206104/",
    "file": "receipts/sources/asiimwe-2025-ukb-allofus-acmi-dementia.htm",
    "inert": true,
    "raw_sha256": "b783a34f5f56061ffc3dcdedbe63974eab09ea70a65663f3345c3c351b4e11f6",
    "sha256": "3d4f62dfc9be5eac206458e1a507068dfa4386f3d365b1f6edcfe23cc509b358",
    "slug": "asiimwe-2025-ukb-allofus-acmi-dementia",
    "title": "Asiimwe et al. 2025, Age Ageing — Anticholinergic medication index & dementia risk (UK Biobank / All of Us, HR 1.15)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/41206104/"
  },
  "zheng-2021-meta-anticholinergic-dementia": {
    "bytes": 140136,
    "captured_at": "2026-07-07",
    "claim": "anticholinergic §2.5 ref[23] Zheng 2021 meta dose-dependent",
    "confirming_quote": "Anticholinergic drugs and the risk of dementia: A systematic review and meta-analysis",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/33933505/",
    "file": "receipts/sources/zheng-2021-meta-anticholinergic-dementia.htm",
    "inert": true,
    "raw_sha256": "5e17aa4d36cb6160ed03beefee8a5f9479fd18a892575c542561f9929d8c51ba",
    "sha256": "c8ea8b305ef58f268e344a334cf9f73bd9e9285e250c68584ba52610afd8d9b1",
    "slug": "zheng-2021-meta-anticholinergic-dementia",
    "title": "Zheng et al. 2021, Neurosci Biobehav Rev — Anticholinergic drugs & dementia risk, systematic review & meta-analysis (dose-dependent)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/33933505/"
  },
  "taylor-rowan-2022-cochrane-anticholinergic": {
    "bytes": 268891,
    "captured_at": "2026-07-07",
    "claim": "anticholinergic §2.5 ref[24] Taylor-Rowan 2022 Cochrane low-certainty",
    "confirming_quote": "Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/35994403/",
    "file": "receipts/sources/taylor-rowan-2022-cochrane-anticholinergic.htm",
    "inert": true,
    "raw_sha256": "2fcfc97f4bf7c11d328cc55dba33bf1e75658362aff26ce836a9f1cfe3c04876",
    "sha256": "5946d4e7b5d1fe047c87dd128a9f34e18508aa8502bee6b7a7794424f0389b55",
    "slug": "taylor-rowan-2022-cochrane-anticholinergic",
    "title": "Taylor-Rowan et al. 2022, Cochrane Database Syst Rev — Anticholinergic burden for prediction of cognitive decline/neuropsychiatric symptoms (low-certainty)",
    "url": "https://pubmed.ncbi.nlm.nih.gov/35994403/"
  },
  "ancelin-2006-esprit-anticholinergic-mci": {
    "bytes": 165979,
    "captured_at": "2026-07-08",
    "claim": "anticholinergic §2.4 ref[5] Ancelin 2006 ESPRIT — cross-sectional MCI (OR 5.12), null incident dementia at 8y",
    "confirming_quote": "Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/16452102/",
    "file": "receipts/sources/ancelin-2006-esprit-anticholinergic-mci.htm",
    "inert": true,
    "raw_sha256": "bf61ebf645c0a86455d62443855cad4efcf0cf0313dbe3d1d75ed06c51aa31e0",
    "sha256": "a500ad033285d35ef8ea0d03a06946eb06a071b7551fcad4d8327347eab9051f",
    "slug": "ancelin-2006-esprit-anticholinergic-mci",
    "title": "Ancelin et al. 2006, BMJ — Non-degenerative MCI & anticholinergic drug use (ESPRIT; cross-sectional MCI OR 5.12, null incident dementia at 8y)"
  },
  "grossi-2019-cfas-anticholinergic-dementia": {
    "bytes": 183373,
    "captured_at": "2026-07-08",
    "claim": "anticholinergic §2.4 ref[6] Grossi 2019 MRC CFAS — ACB3 recurrent-use positive, ACB1-2 null",
    "confirming_quote": "Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort study",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/31638906/",
    "file": "receipts/sources/grossi-2019-cfas-anticholinergic-dementia.htm",
    "inert": true,
    "raw_sha256": "d6202198744aa5e2af7efe52034e4d6832cc7553aa2d0b024a9232d8c7f0ee3b",
    "sha256": "d917880cf4ae0d982613c10a00d47795a0c5304a3c77d0c2d768ce3c2dfbf1e8",
    "slug": "grossi-2019-cfas-anticholinergic-dementia",
    "title": "Grossi et al. 2019, BMC Geriatr — Anticholinergic & benzodiazepine use & incident dementia (MRC CFAS; ACB3 positive, ACB1-2 null)"
  },
  "andre-2018-mapt-anticholinergic-cognition": {
    "bytes": 185409,
    "captured_at": "2026-07-08",
    "claim": "anticholinergic §2.4 ref[8] Andre 2018 MAPT — no association on any of four scales",
    "confirming_quote": "Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/30098049/",
    "file": "receipts/sources/andre-2018-mapt-anticholinergic-cognition.htm",
    "inert": true,
    "raw_sha256": "726119ef29ddc0bc9b87b43793ae80d2845a17cefbc732e5368f900442188892",
    "sha256": "ab4d05e5f50c7d6a4346ee1d619db5f50dd59dc9fd52caa4513ef1c2f7295d53",
    "slug": "andre-2018-mapt-anticholinergic-cognition",
    "title": "Andre et al. 2018, Br J Clin Pharmacol — Anticholinergic exposure & cognitive decline (MAPT; no association across four scales)"
  },
  "hsu-2017-anticholinergic-dementia": {
    "bytes": 154436,
    "captured_at": "2026-07-08",
    "claim": "anticholinergic §2.2 ref[10] Hsu 2017 Taiwan — ACB dose-response with adverse outcomes",
    "confirming_quote": "Comparative Associations Between Measures of Anti-cholinergic Burden and Adverse Clinical Outcomes",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/29133497/",
    "file": "receipts/sources/hsu-2017-anticholinergic-dementia.htm",
    "inert": true,
    "raw_sha256": "1f73813783a323d5c7f6b96066ad4d06babcacceff59365caa6ba0f85d50c06e",
    "sha256": "733da92be173c299a92104e386f01fb2624034363641c492de7ede47695a6a4d",
    "slug": "hsu-2017-anticholinergic-dementia",
    "title": "Hsu et al. 2017, Ann Fam Med — Comparative measures of anticholinergic burden & adverse clinical outcomes (Taiwan; ACB dose-response)"
  },
  "hsu-2021-taiwan-anticholinergic-outcomes": {
    "bytes": 148614,
    "captured_at": "2026-07-08",
    "claim": "anticholinergic §2.2 ref[11] Hsu 2021 Taiwan — multiple anticholinergic prescriptions & adverse outcomes",
    "confirming_quote": "Impact of Multiple Prescriptions With Anticholinergic Properties on Adverse Clinical Outcomes in the Elderly: A Longitudinal Cohort Study in Taiwan",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/33626177/",
    "file": "receipts/sources/hsu-2021-taiwan-anticholinergic-outcomes.htm",
    "inert": true,
    "raw_sha256": "c6f7ccaa820f0311126eac03c20e09a7216aa77408d577df8f61d4f7958b785d",
    "sha256": "3b4fc8959b9fb29af39e24a3ec3cea80135eb9d6e133efadd289fff0d2cf58ef",
    "slug": "hsu-2021-taiwan-anticholinergic-outcomes",
    "title": "Hsu et al. 2021, Clin Pharmacol Ther — Multiple anticholinergic-property prescriptions & adverse clinical outcomes in the elderly (Taiwan longitudinal cohort)"
  },
  "wu-2017-anticholinergic-cognitive-decline-men": {
    "bytes": 163847,
    "captured_at": "2026-07-08",
    "claim": "anticholinergic §2.2 ref[12] Wu 2017 Taiwan — short-term cognitive decline in older men",
    "confirming_quote": "Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/28436193/",
    "file": "receipts/sources/wu-2017-anticholinergic-cognitive-decline-men.htm",
    "inert": true,
    "raw_sha256": "634d28dc256166dc98b9094f906d87a68b1da9f21c4c404d3b911ae35826cca4",
    "sha256": "bfaa93e53dd8224b11a7359e26a729d1e92e4a7236232f9124b233e74f01ab29",
    "slug": "wu-2017-anticholinergic-cognitive-decline-men",
    "title": "Wu et al. 2017, Geriatr Gerontol Int — Anticholinergic medications & short-term cognitive decline in older men (Taiwan retrospective cohort)"
  },
  "risacher-2016-anticholinergic-brain-cognition": {
    "bytes": 239547,
    "captured_at": "2026-07-08",
    "claim": "anticholinergic §5 ref[13] Risacher 2016 ADNI — reduced brain metabolism, greater atrophy, worse cognition (cross-sectional)",
    "confirming_quote": "Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/27088965/",
    "file": "receipts/sources/risacher-2016-anticholinergic-brain-cognition.htm",
    "inert": true,
    "raw_sha256": "bfa8f5eae07b47369cc8f809fad70b9bff8c87519355d80556be92ce074b64cb",
    "sha256": "4bb97a09e886e44e76481014f491ee2bc05851f0f15d3244eac90a709942caf1",
    "slug": "risacher-2016-anticholinergic-brain-cognition",
    "title": "Risacher et al. 2016, JAMA Neurol — Anticholinergic use & cognition, brain metabolism, atrophy in cognitively normal older adults (ADNI)"
  },
  "joung-2019-korea-nhis-anticholinergic-alzheimers": {
    "bytes": 149489,
    "captured_at": "2026-07-08",
    "claim": "anticholinergic §2.2 ref[14] Joung 2019 Korea NHIS — dose-dependent incident Alzheimer's (HR 1.39-1.83)",
    "confirming_quote": "Association of Anticholinergic Use with Incidence of Alzheimer's Disease: Population-based Cohort Study",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/31043628/",
    "file": "receipts/sources/joung-2019-korea-nhis-anticholinergic-alzheimers.htm",
    "inert": true,
    "raw_sha256": "e94f3b30bc4dd656b80c23877cd3a4068fe3175dedba422bdf6a24b2b47f16af",
    "sha256": "4dd1d5f235e2ea0f86071dd383855642fc3ff138db97eab1716f76f31bffcc49",
    "slug": "joung-2019-korea-nhis-anticholinergic-alzheimers",
    "title": "Joung et al. 2019, Sci Rep — Anticholinergic use & incidence of Alzheimer's disease (Korean NHIS; dose-dependent HR 1.39-1.83)"
  },
  "mur-2022-ukbiobank-anticholinergic-dementia": {
    "bytes": 130956,
    "captured_at": "2026-07-08",
    "claim": "anticholinergic §2.2 ref[15] Mur 2022 UK Biobank — burden-trajectory HR 1.094, class-specific / scale-dependent",
    "confirming_quote": "Association between anticholinergic burden and dementia in UK Biobank",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/35434252/",
    "file": "receipts/sources/mur-2022-ukbiobank-anticholinergic-dementia.htm",
    "inert": true,
    "raw_sha256": "e69d65d5cdbb27ab032d50d6189243fafe6e0a651c76505d2e270a1c14701f70",
    "sha256": "632cf6a1dd4131394ab9e0c9d0218a971134c67b0b23e24dbb36e1e9d45d6b1d",
    "slug": "mur-2022-ukbiobank-anticholinergic-dementia",
    "title": "Mur et al. 2022, Alzheimers Dement (N Y) — Anticholinergic burden & dementia (UK Biobank; HR 1.094, class-specific)"
  },
  "painter-2026-kaiser-antimuscarinic-dementia": {
    "bytes": 138544,
    "captured_at": "2026-07-08",
    "claim": "anticholinergic §2.3 ref[19] Painter 2026 Kaiser — bladder antimuscarinic OR 1.27, dose-dependent",
    "confirming_quote": "Antimuscarinic Use and Dementia Incidence in Women With Overactive Bladder",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/41329613/",
    "file": "receipts/sources/painter-2026-kaiser-antimuscarinic-dementia.htm",
    "inert": true,
    "raw_sha256": "6a8ddf3e7b0a28dc21fd72fefae269cb9923991f86628e116c2fdfbbd288d414",
    "sha256": "b45d01271d075c8d3eff1560b3bc27bb8ee8496994b977b07bdac46dae041ed6",
    "slug": "painter-2026-kaiser-antimuscarinic-dementia",
    "title": "Painter et al. 2026, Urogynecology — Antimuscarinic use & dementia incidence in women with OAB (Kaiser Permanente; OR 1.27)"
  },
  "chi-2025-shanghai-anticholinergic-nfl-dementia": {
    "bytes": 187123,
    "captured_at": "2026-07-08",
    "claim": "anticholinergic §2.2/§5 ref[20] Chi 2025 Shanghai — burden HR 1.55, amplified with high plasma NfL",
    "confirming_quote": "Joint Effects of Anticholinergic Burden and Neurofilament Light on Dementia Risk: The Shanghai Aging Study",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/41373116/",
    "file": "receipts/sources/chi-2025-shanghai-anticholinergic-nfl-dementia.htm",
    "inert": true,
    "raw_sha256": "7c948b1b12e2f1967b1eed438ca6759995707c15c5e41031a4f5f9459f4ce6b0",
    "sha256": "6eb85bdb739febbb9804cf82e94f77af621afdf8f260e7ea6e5729e4e0037fd7",
    "slug": "chi-2025-shanghai-anticholinergic-nfl-dementia",
    "title": "Chi et al. 2025, CNS Neurosci Ther — Anticholinergic burden & neurofilament light on dementia risk (Shanghai Aging Study; HR 1.55, NfL-amplified)"
  },
  "franklin-2026-nacc-anticholinergic-mbi": {
    "bytes": 127171,
    "captured_at": "2026-07-08",
    "claim": "anticholinergic §2.2 ref[21] Franklin 2026 NACC — incident mild behavioral impairment (HR 1.07), a dementia prodrome",
    "confirming_quote": "The Impact of Anticholinergic Burden on the Development of Mild Behavioral Impairment",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/42242938/",
    "file": "receipts/sources/franklin-2026-nacc-anticholinergic-mbi.htm",
    "inert": true,
    "raw_sha256": "f3cd6257da8a17befbbbad5cfbaf6f2d6012ab60df6dece12b23168709df1097",
    "sha256": "23776a51367c81fa38fcac5e9b1302f5f32cfe6b8d64f11228c1855fdf06c2f0",
    "slug": "franklin-2026-nacc-anticholinergic-mbi",
    "title": "Franklin et al. 2026, Am J Geriatr Psychiatry — Anticholinergic burden & incident mild behavioral impairment (NACC; HR 1.07)"
  },
  "pham-nguyen-2025-parkinsons-anticholinergic-dementia": {
    "bytes": 176285,
    "captured_at": "2026-07-08",
    "claim": "anticholinergic §2.2 ref[22] Pham Nguyen 2025 — no overall association with Parkinson's-disease dementia",
    "confirming_quote": "Impact of Anticholinergic Burden and Clinical-Demographic Characteristics on Incident Dementia in Parkinson Disease",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/39773244/",
    "file": "receipts/sources/pham-nguyen-2025-parkinsons-anticholinergic-dementia.htm",
    "inert": true,
    "raw_sha256": "20ea60724e75effd07265cc7343eaf3014bf6c2ca6db00feb88e01c0c4059f87",
    "sha256": "029e3048a6dd2e79870d107f41d6af5add131e1eebeb79939475fdf914921be8",
    "slug": "pham-nguyen-2025-parkinsons-anticholinergic-dementia",
    "title": "Pham Nguyen et al. 2025, J Geriatr Psychiatry Neurol — Anticholinergic burden & incident dementia in Parkinson disease (no overall association)"
  },
  "maguire-2026-antimuscarinic-oab-cognitive-review": {
    "bytes": 138525,
    "captured_at": "2026-07-08",
    "claim": "anticholinergic §2.5 ref[25] Maguire 2026 — antimuscarinic OAB systematic review; null short RCTs, positive long cohorts (pooled OR 1.33 / HR 1.24)",
    "confirming_quote": "Antimuscarinic medication used for the treatment of overactive bladder in women and the risk of cognitive decline, cardiovascular disease and mortality-a systematic review",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/41686541/",
    "file": "receipts/sources/maguire-2026-antimuscarinic-oab-cognitive-review.htm",
    "inert": true,
    "raw_sha256": "1d01be0a41240dc54b4501486644558a1e7b7499c6f1a1d0092601cb5298c686",
    "sha256": "ad08bd776e07f903a94a516419c0ec5bbba3efab54c10fc398ab84fc9b5b5f00",
    "slug": "maguire-2026-antimuscarinic-oab-cognitive-review",
    "title": "Maguire et al. 2026, Age Ageing — Antimuscarinic OAB medication & risk of cognitive decline, CVD, mortality (systematic review; null RCT / positive cohort)"
  },
  "schroeck-2016-sleep-medicines-older-adults": {
    "bytes": 125448,
    "captured_at": "2026-07-08",
    "claim": "anticholinergic §1 ref[26] Schroeck 2016 — sleep medicines in older adults; diphenhydramine caution (Beers)",
    "confirming_quote": "Review of Safety and Efficacy of Sleep Medicines in Older Adults",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/27751669/",
    "file": "receipts/sources/schroeck-2016-sleep-medicines-older-adults.htm",
    "inert": true,
    "raw_sha256": "174aaceeb413f536357da80909b51249370c8d34e52d878858cb048959df1e39",
    "sha256": "44ebb86b0bdeaec9ef3269619a71ff33fde946d10c24945004a1f3cb8173f955",
    "slug": "schroeck-2016-sleep-medicines-older-adults",
    "title": "Schroeck et al. 2016, Clin Ther — Review of safety & efficacy of sleep medicines in older adults (diphenhydramine caution / Beers)"
  },
  "fratta-2023-rivastigmine-anticholinergic-delirium": {
    "bytes": 146569,
    "captured_at": "2026-07-08",
    "claim": "anticholinergic §1 ref[27] Fratta 2023 — anticholinergic delirium case (diphenhydramine/dicyclomine), rivastigmine reversal",
    "confirming_quote": "Oral and Transdermal Rivastigmine for the Treatment of Anticholinergic Delirium: A Case Report",
    "content_type": "html",
    "fetched_from": "https://pubmed.ncbi.nlm.nih.gov/37716903/",
    "file": "receipts/sources/fratta-2023-rivastigmine-anticholinergic-delirium.htm",
    "inert": true,
    "raw_sha256": "08226a21b5777b076186ce43c8122b0f5b73d1485744861ca504c2075ea3c59c",
    "sha256": "1dc666f2619a2e627aee0335bf48c98890ae94fded283d96e9569a0b2775d23e",
    "slug": "fratta-2023-rivastigmine-anticholinergic-delirium",
    "title": "Fratta et al. 2023, J Emerg Med — Oral & transdermal rivastigmine for anticholinergic delirium (case report)"
  }
}